Access and Cost-Related Nonadherence to Prescription Medications Among Lupus Patients and Controls: The Michigan Lupus Epidemiology and Surveillance Program.
Deeba MinhasWendy MarderSioban HarlowAfton L HassettSuzanna M ZickCaroline GordonKamil E BarbourCharles G HelmickLu WangJiha LeeAmrita PaddaW Joseph McCuneEmily C SomersPublished in: Arthritis care & research (2021)
SLE patients were more likely than controls from the general population to report cost-related prescription nonadherence, including skipping doses, taking less medicine, and delaying filling prescriptions; yet, <1 in 4 patients asked providers for lower cost medications. Consideration of medication costs in patient decision-making could provide a meaningful avenue for improving access and adherence to medications.
Keyphrases
- end stage renal disease
- ejection fraction
- systemic lupus erythematosus
- chronic kidney disease
- newly diagnosed
- prognostic factors
- healthcare
- peritoneal dialysis
- decision making
- emergency department
- rheumatoid arthritis
- metabolic syndrome
- patient reported outcomes
- skeletal muscle
- adipose tissue
- disease activity
- quality improvement